A similar approach was applied for lung cancer by pooling EphA2-targeting CAR-T cells against tumor cells and fibroblast activation protein-α (FAPα)-targeting CAR-T cells against FAP+ stromal cells. The gene discussed is FAP; the disease is neoplasm.